- Home
- CCSI vs TRDA Comparison
CCSI vs TRDA Comparison
Compare CCSI & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- TRDA
- Stock Information
- Founded
- CCSI 2021
- TRDA 2016
- Country
- CCSI United States
- TRDA United States
- Employees
- CCSI N/A
- TRDA N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- CCSI Technology
- TRDA Health Care
- Exchange
- CCSI Nasdaq
- TRDA Nasdaq
- Market Cap
- CCSI 476.8M
- TRDA 548.2M
- IPO Year
- CCSI N/A
- TRDA 2021
- Fundamental
- Price
- CCSI $25.07
- TRDA $12.64
- Analyst Decision
- CCSI Hold
- TRDA Strong Buy
- Analyst Count
- CCSI 5
- TRDA 3
- Target Price
- CCSI $26.20
- TRDA $25.67
- AVG Volume (30 Days)
- CCSI 96.8K
- TRDA 128.3K
- Earning Date
- CCSI 02-19-2025
- TRDA 03-12-2025
- Dividend Yield
- CCSI N/A
- TRDA N/A
- EPS Growth
- CCSI 16.33
- TRDA N/A
- EPS
- CCSI 4.56
- TRDA 1.55
- Revenue
- CCSI $351,153,000.00
- TRDA $215,232,000.00
- Revenue This Year
- CCSI N/A
- TRDA $47.45
- Revenue Next Year
- CCSI N/A
- TRDA N/A
- P/E Ratio
- CCSI $5.50
- TRDA $8.18
- Revenue Growth
- CCSI N/A
- TRDA 146.92
- 52 Week Low
- CCSI $11.62
- TRDA $11.35
- 52 Week High
- CCSI $27.79
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- CCSI 58.32
- TRDA 24.83
- Support Level
- CCSI $24.22
- TRDA $12.02
- Resistance Level
- CCSI $25.17
- TRDA $18.76
- Average True Range (ATR)
- CCSI 0.78
- TRDA 0.92
- MACD
- CCSI 0.12
- TRDA -0.51
- Stochastic Oscillator
- CCSI 87.93
- TRDA 9.35
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.